- Home
- BLCO vs PAM Comparison
BLCO vs PAM Comparison
Compare BLCO & PAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLCO
- PAM
- Stock Information
- Founded
- BLCO 1853
- PAM 1945
- Country
- BLCO Canada
- PAM Argentina
- Employees
- BLCO N/A
- PAM N/A
- Industry
- BLCO Ophthalmic Goods
- PAM Electric Utilities: Central
- Sector
- BLCO Health Care
- PAM Utilities
- Exchange
- BLCO Nasdaq
- PAM Nasdaq
- Market Cap
- BLCO 4.0B
- PAM 3.9B
- IPO Year
- BLCO 2022
- PAM N/A
- Fundamental
- Price
- BLCO $11.45
- PAM $76.63
- Analyst Decision
- BLCO Hold
- PAM Buy
- Analyst Count
- BLCO 12
- PAM 4
- Target Price
- BLCO $15.59
- PAM $75.88
- AVG Volume (30 Days)
- BLCO 850.1K
- PAM 198.9K
- Earning Date
- BLCO 04-30-2025
- PAM 05-12-2025
- Dividend Yield
- BLCO N/A
- PAM N/A
- EPS Growth
- BLCO N/A
- PAM 32.60
- EPS
- BLCO N/A
- PAM 0.41
- Revenue
- BLCO $4,829,000,000.00
- PAM $1,970,436,590.00
- Revenue This Year
- BLCO $6.97
- PAM $127,194.51
- Revenue Next Year
- BLCO $5.44
- PAM $22.99
- P/E Ratio
- BLCO N/A
- PAM $7.70
- Revenue Growth
- BLCO 11.94
- PAM 21.62
- 52 Week Low
- BLCO $10.45
- PAM $38.58
- 52 Week High
- BLCO $21.69
- PAM $97.55
- Technical
- Relative Strength Index (RSI)
- BLCO 44.25
- PAM 45.40
- Support Level
- BLCO $10.99
- PAM $78.75
- Resistance Level
- BLCO $12.05
- PAM $82.78
- Average True Range (ATR)
- BLCO 0.41
- PAM 3.74
- MACD
- BLCO 0.08
- PAM -0.48
- Stochastic Oscillator
- BLCO 35.38
- PAM 7.72
About BLCO Bausch + Lomb Corporation
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
About PAM Pampa Energia S.A.
Pampa Energia SA and its subsidiaries are engaged in the Energy business. The operating business segments of the firm are Electricity generation, Electricity distribution, Oil and Gas, Petrochemicals, and Holding and other business. The company derives the maximum revenue from the Distribution of energy.